- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$37.34 MnMarket Estimate, 2026
$40.42 MnMarket Forecast, 2034
$76.15 MnCAGR, 2026–2034
8.24%Latin America Gamma Knife Market Size, Growth, Trends & Forecast (2025–2034)
The Latin America gamma knife market was valued at USD 37.34 million in 2025, is estimated to reach USD 40.42 million in 2026, and is projected to reach USD 76.15 million by 2034, growing at a compound annual growth rate (CAGR) of 8.24% from 2026 to 2034. Driven by the rising frequency of neurological illnesses, surging preference for minimally invasive stereotactic radiosurgery, and technological advancements like the Leksell Gamma Knife Icon, the regional market continues to expand steadily.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 37.34 Million
- 2026 Current Valuation: USD 40.42 Million
- 2034 Forecast Valuation: USD 76.15 Million
- Compound Annual Growth Rate (CAGR): 8.24% (2026–2034)
- Dominant Disease Indication: Brain Metastasis & Cancer (holding major share due to rising tumor incidence)
- Fastest-Growing Disease Indication: Trigeminal Neuralgia & AVM (propelled by a shift toward non-invasive neurological procedures)
- Dominant Country Market: Mexico & Brazil (leading regional revenue and procedural volume shares)
Core Market Drivers
- Minimally Invasive Preferences: Growing clinical inclination toward non-invasive neurosurgeries offering higher accuracy, precision, and safety without extended hospital stays.
- Technological Innovations: Rapid adoption of advanced systems like the Leksell Gamma Knife Icon alongside expanding health insurance coverage for radiosurgery.
Primary Market Restraints & Challenges
- High Capital Costs: Steep initial equipment acquisition expenses and high treatment costs restricting wider adoption.
- Awareness Gaps: Limited awareness regarding advanced alternative surgical treatments in developing pockets of the region.
Latin America Gamma Knife Market Segmentation Breakdown
| Segment Category | Leading Sub-Segment (2025 Base) | Fastest-Growing Sub-Segment (2026–2034) |
|---|---|---|
| By Disease Indication | Brain Metastasis & Cancer (dominant volume share driven by high tumor incidence) | Trigeminal Neuralgia & AVM (fastest-growing category due to functional disorder treatment demands) |
| By Country | Brazil (second-largest market by revenue backed by high procedure adoption) | Mexico (projected to lead regional growth via technological innovations and health insurance support) |
Major Industry Players Profiled
Key enterprises shaping the Latin American gamma knife market include Varian Medical Systems, Nordion Inc., ET Medical Group and American Shared Hospital Services, Huiheng Medical Inc., Masep Infini Latin America, Inc., Hokai, Elekta AB, and Cyber Medical Corporation Ltd.
Download Free Sample Report
Latin America Gamma Knife Market Size
The Latin America gamma knife market was valued at USD 37.34 million in 2025, is estimated to reach USD 40.42 million in 2026, and is projected to reach USD 76.15 million by 2034, growing at a CAGR of 8.24% from 2026 to 2034.
MARKET SCENARIO
Increasing acceptance of these devices in surgery centers as a result of the rising frequency of neurological illnesses and the growing inclination for minimally invasive treatments are the factors driving the growth of the market.
Another critical element contributing to the surge in demand for these devices is the fast-expanding demand for the recently created Leksell Gamma Knife Icon, the increased need for technical upgrades, and an increasing understanding of the benefits of this type of radiation therapy.
Furthermore, the increased occurrence of primary brain tumors is expected to enhance demand over the projection period. Moreover, gamma knife therapy's related benefits over other treatment options, such as enhanced accuracy, precision, & treatment safety, are expected to drive up the demand in surgical centers.
The market is expected to grow as gamma knife therapy in neurological treatment grows due to its advantages over traditional operations. For example, it offers higher safety, less damage to surrounding tissues, and micro accuracy while treating the target cells in the brain because it is a non-invasive process.
However, several obstacles may hamper the market's expansion. One of the critical concerns is the expensive expense of implementing the equipment. Furthermore, the cost of treatment is highly high. The tumor's severity also determines the expense of treatment. A lack of awareness about this alternative surgical treatment could stymie market expansion in emerging countries.
Latin America has a moderate revenue share of the global market. The main factors influencing the region are a high incidence of brain tumors, rising awareness among healthcare professionals about non-invasive treatment options like stereotactic surgeries, increased adoption of these instruments in surgery centers, and improving healthcare infrastructure.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | By Disease Indication and Region. |
| Various Analyses Covered | Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Countries Covered | Brazil, Mexico, Argentina, Chile, Rest of Latin America |
| Market Leaders Profiled | Varian Medical Systems, Nordion Inc., ET Medical Group and American Shared Hospital Services, Huiheng Medical Inc., Masep Infini Latin America, Inc., Hokai, Elekta AB, Cyber Medical Corporation Ltd. |
COUNTRY LEVEL ANALYSIS
Geographically, the Latin American gamma knife market is dominated by the global market in terms of volume due to the rising prevalence of malignancies and brain tumors and the growing use of gamma knife tools in surgery facilities, which are all contributing to an increase in disease load.
The Brazil gamma knife market is the second-largest market in terms of revenue due to the increased prevalence of various types of cancer and preference for minimally invasive procedures. In addition, high adoption and acceptance in developed markets are some factors influencing market growth.
The Mexico gamma knife market is expected to lead the Latin American market due to the high success rate of gamma knife procedures, innovations, and developments in technology, and comprehensive health insurance cover for radiosurgery procedures are some of the regional factors influencing the gamma knife market.
Patients with severe conditions in Brazil can be treated with this technique, which is a non-invasive process and can be cured in a few days with no extended hospital stay, allowing them to return to regular life and activity quickly. The gamma knife treatment usually takes a few hours and has minimal to no adverse effects. According to the Leksell Gamma Knife Society, gamma knife technology is generally preferred, and no other radiosurgery technique has a higher level of clinical acceptance.
KEY MARKET PLAYERS
Prominent companies leading the Latin American Gamma Knife Market profiled in the report are Varian Medical Systems, Nordion Inc., ET Medical Group and American Shared Hospital Services, Huiheng Medical Inc., Masep Infini Latin America, Inc., Hokai, Elekta AB, Cyber Medical Corporation Ltd.
MARKET SEGMENTATION
This research report on the Latin America Gamma Knife Market has been segmented and sub-segmented into the following categories.
By Disease Indication
- Brain Metastasis
- Cancer
- Trigeminal Neuralgia
- AVM
- Others
By Country
- Mexico
- Brazil
- Argentina
- Chile
- Rest of Latin America